DrFirst and PatchRx Partner to Combat Medication Non-Adherence

What You Should Know: 

– Healthcare technology leader DrFirst has joined forces with medication adherence company PatchRx to tackle a major healthcare challenge: medication non-adherence. 

– The strategic collaboration aims to improve patient health outcomes and reduce healthcare costs associated with patients not taking their medications as prescribed.

The Problem of Medication Non-Adherence

In the United States alone, medication non-adherence is estimated to contribute to roughly 125,000 deaths and nearly $250 billion in healthcare costs annually. This highlights the critical need for solutions that ensure patients are taking their medications properly.

Comprehensive Patient Medication Adherence

DrFirst and PatchRx combine their respective strengths to provide a more comprehensive picture of patient medication adherence. Here’s how it works:

  • DrFirst’s Population Risk Management Solution: This solution offers the most accurate and up-to-date medication history for patients, including medications purchased outside traditional insurance channels.
  • PatchRx’s Smart Pill Bottle Technology: PatchRx utilizes a patented, discreet smart cap that fits on any standard pill bottle. This cap gathers medication usage data securely, providing valuable insights for both patients and their care teams.

By providing a more holistic view of medication use, DrFirst and PatchRx empower care providers to deliver more targeted and effective care, ultimately leading to a healthier population and a more efficient healthcare system.

“Timing is everything when it comes to effective treatment of complex conditions,” said G. Cameron Deemer, CEO of DrFirst. “Combining our comprehensive prescription fill data with remote monitoring data from PatchRx will give providers the information they need to identify patients who are off schedule with their medications and to intervene early to provide support and prevent health complications.”

Does COVID-19 Persist?

Does COVID-19 persist in the body? With 17 million adults reporting long COVID symptoms like brain fog and fatigue, the idea of viral persistence has

Read More »